Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024

Company Overview - Nyxoah SA is a medical technology company focused on developing and commercializing innovative solutions for treating Obstructive Sleep Apnea (OSA) [9] - The company's lead product is the Genio® system, which is a patient-centered, leadless, and battery-free hypoglossal neurostimulation therapy for OSA [9] Financial Results Announcement - Nyxoah will release its financial results for the second quarter and first half of 2024 on August 6, 2024, after market close [1][6] - A conference call will be hosted by company management on the same day at 10:30pm CET / 4:30pm ET to discuss the financial results [1][6] Conference Call Details - Participants wishing to ask questions must register via a provided link to receive dial-in details and a unique access code [2] - The company recommends registering at least 10 minutes before the call starts to ensure connection [2] - A webcast of the call will be available on the Investor Relations page of Nyxoah's website [7]